1 month ago

India Approves First Dengue Vaccine QDENGA

India Approves First Dengue Vaccine QDENGA
India Gets Its First Dengue Vaccine, QDENGA: Effectiveness, Doses, Eligibility Explained · NDTV

India has approved its first dengue vaccine called QDENGA.

This vaccine is made by a company called Takeda and can protect people from all four types of dengue virus.

Unlike older vaccines, you don't need a blood test before getting it.

The vaccine is given in two doses, three months apart.

It has been shown to be very effective in preventing serious cases of dengue.

India is one of the countries with the most dengue cases, so this vaccine is a big help.

The exact price in India isn't known yet, but the company is working with an Indian partner to make it more affordable.

Key facts

Vaccine Name
QDENGA (TAK-003)
Developer
Takeda
Type
Live-attenuated tetravalent vaccine
Protection
All four dengue virus serotypes
Doses
Two doses, three months apart
Effectiveness
84% against hospitalisation, 61% overall
Approval Status
Approved in over 40 countries
Manufacturing Partner in India
Biological E

Sources

Related news